Get the Weekly Intelligence Brief — top committee picks every Sunday.

CRM vs NICE

Salesforce vs NICE Ltd. — AI-powered side-by-side comparison
CRM
Salesforce
54
Watch
VS
NICE
NICE Ltd.
65
Buy
MetricCRMNICE
AI Score 54 65
Price $205.63 $100.44
P/E Ratio 23.72× 14.36×
ROE 12.6% 15.8%
Revenue Growth YoY
Gross Margin 77.6% 65.1%
Debt / Equity 1.22× 0.02×
Dividend Yield 0.8% 0.0%
RSI (14) 62.4 50.7
Beta 1.152 0.035
Expected Upside +2.8% +17.7%

AI Committee View

Current Innellis committee reasoning for CRM versus NICE.
NICE leads by 11 points.

NICE scores 65/100 (Buy) versus CRM at 54/100 (Watch).

CRM Committee View
60% agreement
5 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case. Risk Analyst remains cautious — bollinger bandwidth of 17.8% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • 4 consecutive earnings beats -- consistent execution — Growth
  • MACD histogram positive -- bullish momentum — Technical
  • Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
  • Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
  • RSI at 71 is in overbought territory — Technical
  • Bollinger bandwidth of 17.8% signals elevated volatility — Risk
NICE Committee View
83% agreement
6 analysts

The primary driver is low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock. The main limiting factor is macd histogram negative -- bearish momentum. The committee is constructive but not yet at full conviction.

Bull Case
  • P/E of 10.8 is inexpensive for the broad market — Value
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock — Risk
Bear Case
  • MACD histogram negative -- bearish momentum — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
CRM Full Analysis NICE Full Analysis